Condition of periodontal tissues in patients with inflammatory intestinal pathology

Numerous evidence of the mutually aggravating influence of periodontal and intestinal pathologies through numerous microbiological, immunological, psychological, and metabolic associations determines the increased interest in the problem of periodontal pathology in patients with inflammatory bowel diseases.

The etiopathogenesis of inflammatory bowel diseases, i. e., ulcerative colitis and Crohn’s disease, is largely similar to periodontitis. Both diseases are associated with an excessive inflammatory reaction of the intestinal mucosa or oral cavity to microbial triggers in the susceptible host.

The purpose of the research is to assess the severity of the clinical course of periodontal pathology in patients with inflammatory bowel diseases.

Intestinal inflammatory diseases and periodontitis are pathologies of inflammatory genesis, chronic progressive course, united by a common pathogenesis consisting in the interaction and mutual aggravation of microbiocenosis disorders and immuno-inflammatory reaction. Inflammatory bowel diseases is one of the most important risk factors for the development and severity of periodontitis. We determined that in patients with inflammatory bowel diseases , the risk of severe periodontitis of the ΙΙΙ/ΙV degree is 2.431 (95 % CI 1.704–3.470), and the etiological contribution of inflammatory bowel diseases to the risk of periodontitis of the ΙΙΙ–ΙV degree is 58.86 %. The presence of a risk factor increases the severity of periodontal pathology.

A significantly higher prevalence of periodontitis was found in patients with inflammatory bowel diseases compared to the comparison group (94.16 % versus 83.97 % (p < 0.001). The presence of inflammatory bowel diseases significantly affects the risk of severe periodontal disease.

1. Amaliya A., Laine M. L., Delanghe J. R., Loos B. G., Van Wijk A. J., Van der Velden U. Java project on periodontal diseases: periodontal bone loss in relation to environmental and systemic conditions. Journal of Clinical Periodontology, 2015, vol. 42, no. 4, pp. 325–332. https://doi.org/10.1111/jcpe.12381

2. Ananthakrishnan A. N. Epidemiology and risk factors for IBD. Nature Reviews Gastroenterology and Hepatology, 2015, vol. 12, no. 4, pp. 205–217. https://doi.org/10.1038/nrgastro.2015.34

3. Brito F., Zaltman C., Carvalho A. T. P., Fischer R. G., Persson R., Gustafsson A., Figueredo C. M. S. Subgingival microflora in inflammatory bowel diseasepatients with untreated periodontitis. European Journal of Gastroenterology and Hepatology, 2013, vol. 25, no. 2, pp. 239–245. https://doi.org/10.1097/meg.0b013e32835a2b70

4. Bunte K., Beikler T. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases. International Journal of Molecular Sciences, 2019, vol. 20, no. 14, art. 3394. https://doi.org/10.3390/ijms20143394

5. Cătană C.-S., Neagoe I. B., Cozma V., Magdaş C., Tăbăran F., Dumitraşcu D. L. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease. World Journal of Gastroenterology, 2015, vol. 21, no. 19, pp. 5823–5830. https://doi.org/10.3748/wjg.v21.i19.5823

6. Gemmell M. R., Berry S., Mukhopadhya I., Hansen R., Nielsen H. L., Bajaj-Elliott M., Nielsen H., Hold G. L. Comparative genomics of Campylobacter concisus: Analysis of clinical strains reveals genome diversity and pathogenic potential. Emerging Microbes and Infections, 2018, vol. 7, no. 1, art. 116. https://doi.org/10.1038/s41426-018-0118-x

7. Han Y. W. Fusobacterium nucleatum: a commensal-turned pathogen. Current Opinion in Microbiology, 2015, vol. 23, pp. 141–147. https://doi.org/10.1016/j.mib.2014.11.013

8. Hsu T., Gemmell M. R., Franzosa E. A., Berry S., Mukhopadhya I., Hansen R. [et al.]. Comparative genomics and genome biology of Campylobacter showae. Emerging Microbes and Infections, 2019, vol. 8, no. 1, pp. 827–840. https://doi.org/10.1080/22221751.2019.1622455

9. Huh J.-W., Roh T.-Y. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis. BMC Microbiology, 2020, vol. 20, no. 1, art. 208. https://doi.org/10.1186/s12866-020-01887-4

10. Atarashi K., Suda W., Luo Ch., Kawaguchi T., Motoo I., Narushima S. [et al.]. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science, 2017, vol. 358, no. 6361, pp. 359–365. https://doi.org/10.1126/science.aan4526

11. Benakanakere M., Abdolhosseini M., Hosur K., Finoti L. S., Kinane D. F. TLR2 Promoter Hypermethylation Creates Innate Immune Dysbiosis. Journal of Dental Research, 2015, vol. 94, no. 1, pp. 183–191. https://doi.org/10.1177/0022034514557545

12. Lundmark A., Davanian H., Båge T., Johannsen G., Koro C., Lundeberg J., Yucel-Lindberg T. Transcriptome analysis reveals mucin 4 to be highly associated with periodontitis and identifies pleckstrin as a link to systemic diseases. Scientific Reports, 2015, vol. 5, art. 18475. https://doi.org/10.1038/srep18475

13. Tomura M., Yoshida N., Tanaka J., Karasawa S., Miwa Y., Miyawaki A., Kanagawa O. Monitoring cellular movement in vivo with photoconvertible fluorescence protein “Kaede” transgenic mice. Proceedings of the National Academy of Sciences, 2008, vol. 105, no. 31, pp. 10871–10876. https://doi.org/10.1073/pnas.0802278105

14. Tsuzuno T., Takahashi N., Yamada-Hara M., Yokoji‐Takeuchi M., Sulijaya B., Aoki‐Nonaka Yu., Matsugishi A., Katakura K., Tabeta K., Yamazaki K. Ingestion of Porphyromonas gingivalis exacerbates colitis via intestinal epithelial barrier disruption in mice. Journal of Periodontal Research, 2021, vol. 56, no. 2, pp. 275–288. https://doi.org/10.1111/jre.12816

15. Man S. M. The clinical importance of emerging Campylobacter species. Nature Reviews Gastroenterology and Hepatology, 2011, vol. 8, no. 8, pp. 669–685. https://doi.org/10.1038/nrgastro.2011.191

16. Ni J., Wu G. D., Albenberg L., Tomov V. T. Gut microbiota and IBD: causation or correlation? Nature Reviews Gastroenterology and Hepatology, 2017, vol. 14, no. 10, pp. 573–584. https://doi.org/10.1038/nrgastro.2017.88

17. Papapanou P. N., Sanz M., Buduneli N., Dietrich T., Feres M., Fine D. H. [et al.]. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. Journal of Periodontology, 2018, vol. 89, suppl. 1, pp. S173–S182. https://doi.org/10.1002/jper.17-0721

18. Schmidt T. S. B., Hayward M. R., Coelho L. P., Li S. S., Costea P. I., Voigt A. Y. [et al.]. Extensive transmission of microbes along the gastrointestinal tract. eLife, 2019, vol. 8, art. e42693. https://doi.org/10.7554/elife.42693

19. Chapple I. L. C., Mealey B. L., Van Dyke T. E., Bartold P. M., Dommisch H., Eickholz P., Geisinger M. L. [et al.]. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. Journal of Periodontology, 2018, vol. 45, suppl. 1, pp. S74–S84. https://doi.org/10.1002/jper.17-0719

20. She Y.-Y., Kong X.-B., Ge Y.-P., Liu Z.-Y., Chen J.-Y., Jiang J.-W., Jiang H.-B., Fang S.-L. Periodontitis and inflammatory bowel disease: a meta-analysis. BMC Oral Health, 2020, vol. 20, no. 1, art. 67. https://doi.org/10.1186/s12903-020-1053-5

21. Shi B., Lux R., Klokkevold P., Chang M., Barnard E., Haake S., Li H. The subgingival microbiome associated with periodontitis in type 2 diabetes mellitus. The ISME Journal, 2020, vol. 14, no. 2, pp. 519–530. https://doi.org/10.1038/s41396019-0544-3

22. Socransky S. S., Haffajee A. D., Cugini M. A., Smith C., Kent R. L. Microbial complexes in subgingival plaque. Journal of Clinical Periodontology, 1998, vol. 25, no. 2, pp. 134–144. https://doi.org/10.1111/j.1600-051x.1998.tb02419.x

23. Strauss J., Kaplan G. G., Beck P. L., Rioux K., Panaccione R., DeVinney R., Lynch T., Allen-Vercoe E. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflammatory Bowel Diseases, 2011, vol. 17, no. 9, pp. 1971–1978. https://doi.org/10.1002/ibd.21606

24. Wu T., Xu F., Su C., Li H., Lv N., Liu Y., Gao Yu., Lan Y., Li J. Alterations in the Gut Microbiome and Cecal Metabolome During Klebsiella pneumoniae-Induced Pneumosepsis. Frontiers in Immunology, 2020, vol. 11, art. 1331. https://doi.org/10.3389/fimmu.2020.01331

25. Cai Z., Zhu T., Liu F. Zhuang Z., Zhao L. Co-pathogens in Periodontitis and Inflammatory Bowel Disease. Frontiers in Medicine, 2021, vol. 8, art. 723719. https://doi.org/10.3389/fmed.2021.723719